Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.30 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3824058 | 0.86 | ALDH1A1 (0.46) | TSHRALDH1A1TP53NPC1RAB9A | |
| SCHEMBL3821521 | 0.84 | ALDH1A1 (0.46) | TSHRALDH1A1TP53PHF8KDM2A | |
| SCHEMBL3823996 | 0.82 | ALDH1A1 (0.50) | TSHRALDH1A1TP53PHF8KDM2A | |
| SCHEMBL1869025 | 0.79 | PHF8 (0.46) | ALDH1A1PHF8KDM2A | |
| SCHEMBL3763074 | 0.78 | NPC1 (0.36) | TSHRALDH1A1NPC1RAB9AKMT2A | |
| SCHEMBL19133282 | 0.77 | ALDH1A1 (0.45) | ALDH1A1NPC1RAB9AKMT2APHF8 | |
| SCHEMBL19924618 | 0.77 | ALDH1A1 (0.43) | TSHRALDH1A1NPC1RAB9A | |
| SCHEMBL4034999 | 0.76 | ALDH1A1 (0.34) | ALDH1A1NPC1RAB9A | |
| SCHEMBL645133 | 0.76 | — | — | |
| SCHEMBL3297922 | 0.75 | ALDH1A1 (0.46) | ALDH1A1NPC1RAB9AKMT2APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1987026-B1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR THE TREATMENT OF THROMBOEMBOLITIC DISORDERS | BAYER HEALTHCARE AG (DE) | 2009-08-26 | — | — | EP | disclosed |
| EP-1987026-A1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR THE TREATMENT OF THROMBOEMBOLITIC DISORDERS | Bayer HealthCare AG (DE) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007093328-A1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR THE TREATMENT OF THROMBOEMBOLITIC DISORDERS | BAYER HEALTHCARE AG (DE) | 2007-08-23 | — | — | WO | disclosed |